Gene One Proposal

Gene One Proposal

Gene One is a biotechnology company that specializes in ridding diseases of produce, so farmers can grow their crops without the use of pesticides (University of Phoenix, n.d.). Gene One Company is in the process of planning the transition of making the company public and implementing leadership change. With this change, Gene One will strategize to accomplish its goals and objectives. The following paragraphs will define two types of strategies—innovative strategy and Initial Public Offering (IPO) in implementing change to help the company determine which to use. Furthermore, the paper recommends how to implement these strategies to reach desired outcome and innovative culture.

Innovative Strategy

Innovative strategy is about striving to achieve significant and distinctive innovations with the help of a systematic structure that includes effective channels of communication and authority as well as implementation of long-term commitment policies (Robbins & Judge, 2007, p. 504). Gene One needs to determine and implement a leadership change, and the innovative strategy complements the company’s focus. According to Gene One’s Executive Summary, the company’s focus involves eight areas, they include

1. Minimum of 40% revenue growth per year,

2. Offer an IPO in 36 months,

3. Identify the key factors needed to implement the IPO,

4. Develop a certified financial statement to the Securities and Exchange Commission with acknowledgement from the CFO and CEO,

5. Decide what kind of investors the company wants,

6. Find two to three investment firms/underwriters to make the initial offering,

7. IPO initial offering at lowest stock price, and

8. Identify senior leadership and Board positions to upgrade and realize strategy and comply with SEC requirements (University of Phoenix, n.d.).

An innovative strategy that includes a systematic structure will help the company identify key factors to implement the IPO. In the long-term, developing...